Main
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
Register:
|
ANZCTR |
Last refreshed on:
|
1 October 2018 |
Main ID: |
ACTRN12617001474347 |
Date of registration:
|
19/10/2017 |
Prospective Registration:
|
Yes |
Primary sponsor: |
|
Public title:
|
Pancreatic cancer: Understanding Routine Practice and Lifting End Results (PURPLE). A Prospective Pancreatic Cancer Clinical Registry
|
Scientific title:
|
Pancreatic cancer: Understanding Routine Practice and Lifting End Results (PURPLE). A Prospective Pancreatic Cancer Clinical Registry |
Date of first enrolment:
|
15/02/2017 |
Target sample size:
|
800 |
Recruitment status: |
Recruiting |
URL:
|
http://www.anzctr.org.au/ACTRN12617001474347.aspx |
Study type:
|
Observational |
Study design:
|
|
Phase:
|
|
|
Key inclusion & exclusion criteria
|
Health Condition(s) or Problem(s) studied
|
Metastatic Pancreatic Cancer
|
Newly diagnosed Pancreatic Cancer
|
Pancreatic Cancer
|
Intervention(s)
|
The following end-points will be evaluated in this study: Time to progression from primary diagnosis (TTP). Progression-free survival (PFS). Overall survival (OS). This project is a multi-centre, prospective cohort study that will aim to enrol 800 patients at participating sites. It involves collection of data into the PURPLE registry, linkage and analysis of data via a WEHI developed database. Comprehensive clinicopathological data will be collected, start and stop dates for all systemic therapies will be captured as well as treatment response data for each therapy used, the reason for any change in treatment, and the date of disease progression. Data related to any resection of primary and or metastatic disease will be collected.
|
Source(s) of Monetary Support
|
Results
|
Results available:
|
|
Date Posted:
|
|
Date Completed:
|
|
URL:
|
|
|
|